Search Results - "Kozak, Raymond"

The Antianginal Drug Trimetazidine Shifts Cardiac Energy Metabolism From Fatty Acid Oxidation to Glucose Oxidation by Inhibiting Mitochondrial Long-Chain 3-Ketoacyl Coenzyme A Thiolase by Kantor, Paul F, Lucien, Arnaud, Kozak, Raymond, Lopaschuk, Gary D

“…ABSTRACTTrimetazidine is a clinically effective antianginal agent that has no negative inotropic or vasodilator properties. Although it is thought to have…”
Get full text

The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme by Kantor, Paul F, Arnaud Lucien, Kozak, Raymond, Lopaschuk, Gary D

“…Trimetazidine is a clinically effective antianginal agent that has no negative inotropic or vasodilator properties. Although it is thought to have direct…”
Get full text

Synergism between prostaglandin E2 and isoproterenol in stimulating glucose oxidation in the heart by Olley, P M, Kasserra, J, Kozak, R, Lopaschuk, G D

“…The increase in cardiac contractile function following adrenergic stimulation is accompanied by increased glucose metabolism. Since prostaglandin E2 (PGE2) can…”
Get more information